LBA
MDT icon

Lowell Blake & Associates’s Medtronic MDT Stock Holding History

Lowell Blake & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,455
Closed -$221K – 54
2020
Q1 		$221K Hold
2,455
– – 0.28% 47
2019
Q4 		$279K Buy
+2,455
New +$269K 0.31% 46

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Lowell Blake & Associates's MDT Position: Q2 2020 in Review

Lowell Blake & Associates sold out of Medtronic (MDT) in Q2 2020, closing a stake of 2,455 shares — an estimated $221K sold.

Lowell Blake & Associates first reported a position in MDT in Q4 2019 and held it in 2 quarters. The position peaked at $279K in Q4 2019. 1,760 funds tracked by Wall St. Rank hold MDT as of Q2 2020.

  • Lowell Blake & Associates reported no remaining Medtronic position as of Q2 2020 after selling out during the quarter.
  • Lowell Blake & Associates sold 2,455 Medtronic shares in Q2 2020, an estimated $221K.
  • Lowell Blake & Associates first reported a position in Medtronic in Q4 2019 and held it in 2 quarters.
  • Lowell Blake & Associates's Medtronic position peaked at $279K in Q4 2019.
  • 1,760 funds tracked by Wall St. Rank held Medtronic as of Q2 2020.

Based on Lowell Blake & Associates's 13F filing for Q2 2020, filed 13 Aug 2020.